Professor John Newell-Price appointed new clinical research director at Sheffield Teaching Hospitals

Professor Newell-Price is recognised nationally and internationally for his extensive scientific and clinical expertise in pituitary and adrenal disorders, genetic endocrine disease, neuroendocrine tumours and cancer.

In 2023 he was elected as the President of the Endocrine Society and together with colleagues, he has developed Sheffield as a world-leading patient-centred clinical endocrine service where clinical and translational research and innovation is embedded, being funded by UK Research and Innovation (UKRI), industry and charities.

He has led nationally with NHS England and the Royal College of Physicians to set standards of care in his field, and internationally on numerous evidence-based clinical practice guidelines. In addition to his extensive leadership, Professor Newell-Price has a longstanding commitment to developing, championing and training medical students and researchers in the early stages of their careers. He also has a long track-record of working closely with patient groups.

Professor Newell-Price will be part of the team which drives forward the Trust’s new research and innovation strategy which also supports the 10 Year Health Plan for England, aiming to create a future-ready NHS using new technologies, medicines, and innovations to support prevention and treatment of clinical conditions. He will also be responsible for co-leading the Clinical Research and Innovation Office (CRIO), a joint research and innovation office led by Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield.

Professor John Newell-Price, Honorary Consultant Physician at Sheffield Teaching Hospitals NHS Foundation Trust and Professor of Endocrinology at the University of Sheffield, said:

“I am honoured to take on the role of clinical research director at Sheffield Teaching Hospitals NHS Foundation Trust. Our research and innovation, led by our senior research and innovation leadership and talented CRIO team, is built on a foundation of clinically excellent collaboration and innovation.

“I look forward to working with everyone including patients, staff, public, industry, universities, charities and stakeholders to ensure our research and innovation continues to make a real difference to patients’ lives in the region and beyond.

“I am also privileged to be taking on this role from Professor Simon Heller, who has served in the position for 19 years, and am indebted to him for his invaluable leadership and the significant strides he has made in advancing clinical research and innovation at Sheffield Teaching Hospitals.”

Dr Nick Lyons, Chief Medical Officer (Development) at Sheffield Teaching Hospitals NHS Foundation Trust, said:

“Professor Newell-Price brings a wealth of experience to the role and is passionate about integrating patient-centred care with leading-edge scientific research to foster innovation.

“His appointment comes at a key juncture for NHS research and innovation, which is highlighted as central to ensuring the NHS meets future healthcare needs in the NHS 10 Year Plan. He will also strengthen vital relationships with patients, public, staff, industry, Universities, charities and key partner organisations.

“I, too, would like to pass on my enormous gratitude to Professor Simon Heller. Under his guidance, the Trust has seen remarkable progress in establishing pioneering research programmes, strengthening multidisciplinary collaborations, and delivering innovation that has led to real improvements in patient care.”

Professor Tracey Moore, interim vice president and head of the faculty of health at the University of Sheffield, said:

“Professor Newell-Price's exceptional leadership and internationally recognised contributions to endocrine research have made a significant impact on patient care and clinical research across South Yorkshire and beyond.

"His commitment to innovation and collaboration will be invaluable in strengthening the CRIO partnership between Sheffield Teaching Hospitals and the University of Sheffield, and ensuring pioneering research continues to be translated into real-world benefits for patients.

"I would like to warmly congratulate Professor John Newell-Price and look forward to supporting him as he brings his vision and expertise to this important new role. I would also like to extend my sincere thanks to Professor Simon Heller for his outstanding dedication to the role."

Professor Newell-Price commenced in post from December 1, 2025.